FILSPARI (sparsentan) — NDC 68974-200 by Travere Therapeutics, Inc.
FILSPARI (sparsentan) — NDC 68974-200 by Travere Therapeutics, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: FILSPARI; Generic name: sparsentan; Product NDC: 68974-200.
| Brand name | FILSPARI |
|---|---|
| Generic name | sparsentan |
| Product NDC | 68974-200 |
| Labeler | Travere Therapeutics, Inc. |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | SPARSENTAN 200 mg/1 |
| Pharmacologic class | Angiotensin 2 Receptor Blocker [EPC], Angiotensin 2 Type 1 Receptor Antagonists [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Induc |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →